About Assisted Reproductive Technology Assisted reproductive technology (ART) is a wide range of procedures that are used to treat infertility in men and women. Generally, ART procedures include techniques, such as IVF, ZIFT, GIFT, ICSI, and artificial insemination, which help individuals to conceive a child. Technavio’s analysts forecast the global assisted reproductive technology market to grow at a CAGR of 4.11% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global assisted reproductive technology market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of ART solutions to end-users, such as infertility clinics and hospitals. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Assisted Reproductive Technology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating... Research Beam Model: Research Beam Product ID: 1237513 3500 USD New
Global Assisted Reproductive Technology Market 2017-2021
 
 

Global Assisted Reproductive Technology Market 2017-2021

  • Category : Medical Devices
  • Published On : February   2017
  • Pages : 90
  • Publisher : Technavio
 
 
 
About Assisted Reproductive Technology
Assisted reproductive technology (ART) is a wide range of procedures that are used to treat infertility in men and women. Generally, ART procedures include techniques, such as IVF, ZIFT, GIFT, ICSI, and artificial insemination, which help individuals to conceive a child.

Technavio’s analysts forecast the global assisted reproductive technology market to grow at a CAGR of 4.11% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global assisted reproductive technology market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of ART solutions to end-users, such as infertility clinics and hospitals.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Assisted Reproductive Technology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Vitrolife
• Ferring Pharmaceuticals
• Irvine Scientific
• Cook Medical
Other prominent vendors
• CellCura
• EMD Serono
• Esco Micro
• IKS International (Gonagen Medikal)
• INVO Bioscience
• IVFtech
• CRITEX (MedITEX)
• Pantec Biosolutions
• Research Instruments
• Smiths Medical
Market driver
• Increase in awareness of ART
• For a full, detailed list, view our report

Market challenge
• Lack of strict regulatory oversight and limited reimbursements
• For a full, detailed list, view our report

Market trend
• Increasing number of single-parent families
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Vendor analysis
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by application
• Market overview
• Fertility clinics
• Hospitals
• Others
PART 07: Geographical segmentation
• Market overview
• EMEA
• Americas
• APAC
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• Vitrolife
• Ferring Pharmaceuticals
• Irvine Scientific
• Cook Medical
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
PART 16: Explore Technavio
List of Exhibits
Exhibit 01: Key countries
Exhibit 02: Global ART market segmentation: Overview
Exhibit 03: Product offerings
Exhibit 04: Snapshot: Global ART market 2016-21
Exhibit 05: Key pointers for vendors
Exhibit 06: Growth and success factors of vendors
Exhibit 07: Assessment of regulatory landscape
Exhibit 08: Timeline of fertility treatment procedures
Exhibit 09: Stages of infertility treatment
Exhibit 10: Global hubs for fertility tourism
Exhibit 11: Global ART market 2016-2021 ($ billions)
Exhibit 12: PESTLE analysis of ART market
Exhibit 13: Five forces analysis
Exhibit 14: Global ART market segmentation by end-users 2016 and 2021
Exhibit 15: Opportunity analysis of ART market
Exhibit 16: Fertility clinics in ART market 2016-2021 ($ billions)
Exhibit 17: Number of visitors to fertility clinics in medical tourism hotspots worldwide 2013-2015
Exhibit 18: Hospitals in ART market 2016-2021 ($ billions)
Exhibit 19: Top ten countries with most number of hospitals 2014-2015
Exhibit 20: Others in ART market 2016-21 ($ billions)
Exhibit 21: Global ART market segmentation by geography 2016-2021
Exhibit 22: Snapshot: Global ART market by geography
Exhibit 23: EMEA in ART market 2016-2021 ($ billions)
Exhibit 24: Americas in ART market 2016-2021 ($ billions)
Exhibit 25: US birth rates by women's age group
Exhibit 26: APAC in ART market 2016-2021 ($ billions)
Exhibit 27: Obesity prevalence in US
Exhibit 28: Infertility rates by age
Exhibit 29: ART procedures in the US 2002-2011 (in thousands)
Exhibit 30: Global urban population (%)
Exhibit 31: Change in the world’s population by age 2010-2050 (%)
Exhibit 32: Impact of drivers
Exhibit 33: Cost breakdown of IVF by various stages in US
Exhibit 34: Impact of drivers and challenges
Exhibit 35: Single parent families by gender in US 2015
Exhibit 36: Increase in pregnancy rates among women age 30 and older (per thousand) in US
Exhibit 37: Strategic initiatives
Exhibit 38: Notable M&A activity
Exhibit 39: Same sex married couples in US
Exhibit 40: Competitive parameters
Exhibit 41: Strategic success factor of consideration for companies
Exhibit 42: Vitrolife: Profile
Exhibit 43: Vitrolife: Strength analysis
Exhibit 44: Vitrolife: Strategy assessment
Exhibit 45: Vitrolife: Opportunity assessment
Exhibit 46: Ferring Pharmaceuticals: Profile
Exhibit 47: Ferring Pharmaceuticals: Strength analysis
Exhibit 48: Ferring Pharmaceuticals: Strategy assessment
Exhibit 49: Ferring Pharmaceuticals: Opportunity assessment
Exhibit 50: Irvine Scientific; Strength analysis
Exhibit 51: Irvine Scientific: Strategy assessment
Exhibit 52: Irvine Scientific: Opportunity assessment
Exhibit 53: Cook Medical: Strength analysis
Exhibit 54: Cook Medical strategy assessment
Exhibit 55: Cook Medical opportunity assessment

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT